For brands that impact the health and wellness of our society.
A custom built digital sales platform has resulted in a 92% uplift in people accessing Hepatitis B treatment.
More than 9 million people worldwide have been reached to raise awareness of hearing health.
23% more Australian men suffering from testosterone deficiency have accessed treatment.
57% more Australians who suffer from Seasonal Allergic Conjunctivitis received the latest OTC treatment.
Australian Allergic Rhinitis sufferers are 23% more likely to be prescribed effective treatment.
The number of Australians accessing a dementia helpline has increased by 44%.
Australian GPs’ attention to the early signs of dementia has increased by 77%.
Reviewing the legalised shooting of vulnerable grey-headed flying foxes has been put on the NSW state government’s agenda.
There has been a 45% increase in the number of Australians achieving their LDL target.
2/3 of schizophrenia treating physicians now believe that Australian patients prefer wafers to tablets.
100% of Australian HIV treating physicians believe a digital sales tool facilitates a more engaging discussion.
The number of Australian Pharmacists that agree ibuprofen is as tolerable as paracetamol at OTC doses has doubled.
Pharmacies in an Australian S3 pain medication programme have seen a 22% improvement in their S3 business.
Australian Pharmacy Assistants have completed 21,000+ educational modules on pain management.
Australian HCPs have engaged in 1,800+ hours of webinar-based diabetes education.
2,600+ Australian HCPs now have a better understanding of best practice diabetes care.
3 million Australians now regularly think about their lung health.
The world’s largest remaining red gum forests have been given national park status.
2/3 Australian pharmacy assistants now actively engage in online education.
The role of hormone therapy in treating Asian prostate cancer patients has been agreed by 153 urologists at an APAC Summit.
200 GI specialists have collaborated at an APAC Masterclass to solve the unmet needs of patients with acid-related disease.
by Rob Mortimer, 27 July 2017